Literature DB >> 18501941

Oligomerisation of pneumolysin on cholesterol crystals: similarities to the behaviour of polyene antibiotics.

Andreas F-P Sonnen1, Arthur J Rowe, Peter W Andrew, Robert J C Gilbert.   

Abstract

Pneumolysin is a cytolytic toxin of Streptococcus pneumoniae, a causative agent of pneumonia and meningitis. The prepore and pore states of pneumolysin have recently been investigated by cryo-electron microscopy and atomic force microscopy, confirming the existence of arc-shaped as well as ring-form oligomers. Here we provide further insights into the pneumolysin oligomer by studying the interaction of pneumolysin with cholesterol crystals, comparing the results to those obtained for polyene antibiotics, which also bind cholesterol.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18501941     DOI: 10.1016/j.toxicon.2008.03.032

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  3 in total

1.  Septic polyarthritis caused by Streptococcus pneumoniae: primary pneumococcal pneumonia as a risk factor in older patients? A case report.

Authors:  Susanne Habelt; Adrian Schwaller; Albert Hollinger; Ladislav Mica
Journal:  BMJ Case Rep       Date:  2009-12-03

2.  Changes in astrocyte shape induced by sublytic concentrations of the cholesterol-dependent cytolysin pneumolysin still require pore-forming capacity.

Authors:  Christina Förtsch; Sabrina Hupp; Jiangtao Ma; Timothy J Mitchell; Elke Maier; Roland Benz; Asparouh I Iliev
Journal:  Toxins (Basel)       Date:  2011-01-07       Impact factor: 4.546

3.  All major cholesterol-dependent cytolysins use glycans as cellular receptors.

Authors:  Lucy K Shewell; Christopher J Day; Freda E-C Jen; Thomas Haselhorst; John M Atack; Josephine F Reijneveld; Arun Everest-Dass; David B A James; Kristina M Boguslawski; Stephan Brouwer; Christine M Gillen; Zhenyao Luo; Bostjan Kobe; Victor Nizet; Mark von Itzstein; Mark J Walker; Adrienne W Paton; James C Paton; Victor J Torres; Michael P Jennings
Journal:  Sci Adv       Date:  2020-05-22       Impact factor: 14.136

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.